Aiming to improve the conditions of people living with neurological disorders, the European Federation of Neurological Associations (EFNA) will focus on three advocacy themes for 2020-2025: Access to treatment, services and support Stigma, isolation and discrimination and Patient empowerment, engagement… Continue Reading

No change to the conditions of use of the direct oral anticoagulants Eliquis (apixaban), Pradaxa (dabigatran etexilate) and Xarelto (rivaroxaban) is needed following a review of the results of a European study of real-world data for these medicines. The study,… Continue Reading

EU and national authorities are continuing their work to prevent and manage the presence of nitrosamine impurities in EU medicines. Nitrosamines are classified as probable human carcinogens (substances that could cause cancer) based on animal studies. They are present in… Continue Reading

During this time of uncertainty regarding COVID-19, the 30th Alzheimer Europe Conference #30AEC is still planned to take place in Bucharest from 20-22 October 2020. Our call for abstracts is open, as are registrations, with Early Bird fees available until… Continue Reading

As part of the EU’s Civil Protection Mechanism, on 19 March, the European Commission decided to create a Strategic RescEU Stockpile of medical equipment such as ventilators and protective masks to help EU countries in the context of the COVID-19… Continue Reading

·       What does inspire you outside neurology?  History. Knowing what happened in the past helps understanding what occurs currently and what the future could be. There are similarities between the reasoning of medical researchers and that of historians: search for original… Continue Reading

The COVID-19 pandemic poses a major challenge that has a disruptive effect on European health systems and societies. European health professionals are working around the clock to save the lives of European patients, and governments and the EU Institutions are… Continue Reading

RETHINKING MS in Europe, offering tangible policy changes to improve the lives of people living with MS across Europe, went live during Brain Awareness Week On the occasion of the Brain Awareness Week (16-22 March 2020), the European Brain Council… Continue Reading

WHO Europe launches an on-line consultation on the update of the WHO Comprehensive (Global) Mental Health Action Plan – GMHAP As determined by the World Health Assembly last year, WHO’s Comprehensive Mental Health Action Plan 2013-2020 has been extended to… Continue Reading

Rare Disease Day was launched in 2008 by EURORDIS, an alliance of patient organisations, and its Council of National Alliances, starting as a European event. It is now a major international event celebrated by rare disease organizations across the globe with… Continue Reading

Neurologists working at the Reggio Emilio Hospital in Italy have provided a presentation on the impact the COVID-19 pandemic has had on their Neurology Unit and their experience treating COVId-19 patients with neurological conditions.

This article addresses the difficult issue of how to allocate overstretched resources during a pandemic and proposes six recommendations based on principles of equality and maximising benefits.

In a marathon debate of the European Council on 20-21 February, where the heads of state and government European Member States meet, representatives failed to agree on the EU budget for 2021-2027. This budget includes Horizon Europe, the next funding programme for research and innovation. Long term budget negotiations are known to be difficult, but this time around the departure of the UK, a major budget contributor, intensified the discussions. It is likely that more European summits will be needed to come to conclusion on this topic.

The former co-chairs of the Scientific Panel on Higher Cortical Functions Masud Husain & Lüder Deecke explain the work and aims of the panel.